Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04108299 · ClinicalTrials.gov registry record · NA
Family Intervention for Chinese Americans With Type 2 Diabetes
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT04108299 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 46 participants.
The verdict
NCT04108299, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
The goal of this pilot study is to examine the feasibility and acceptability of a family-oriented SMS intervention in 30 Chinese Americans with T2D and their family members. Participants will be randomized to one of 2 arms (n=15 each): 1) wait-list control and 2) SMS intervention. Both groups will continue to receive standard of care treatment for their T2D. The SMS group will receive brief lifestyle counseling videos via SMS links. At the end of the study, the wait-list control group will be provided the opportunity to receive the counseling videos.
Interventions
- BEHAVIORAL Wait-list control group
- BEHAVIORAL SMS intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2021-04-21 |
| Est. Completion | 2022-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04108299
The ClinicalTrials.gov registry entry for NCT04108299 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Wait-list control group is the first listed.
NCT04108299 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04108299 about?
NCT04108299 is a clinical study titled "Family Intervention for Chinese Americans With Type 2 Diabetes". The goal of this pilot study is to examine the feasibility and acceptability of a family-oriented SMS intervention in 30 Chinese Americans with T2D and their family members. Participants will be randomized to one of 2 arms (n=15 each): 1) wait-list control and 2) SMS intervention. Both groups will c...
What is the current status of trial NCT04108299?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2021-04-21. Estimated completion is 2022-07-30.
What interventions are being tested in trial NCT04108299?
The interventions under investigation include: Wait-list control group (BEHAVIORAL), SMS intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04108299?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.